Safety and Efficacy of Remimazolam in ASA III and IV Patients Undergoing Colonoscopy
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center,
parallel group study comparing remimazolam to placebo, with an additional open-label arm for
midazolam, in American Society of Anesthesiologists (ASA) Grade III and IV patients (ASA
status evaluated by an anesthesiologist not otherwise involved in the study) undergoing a
colonoscopy for diagnostic or therapeutic reasons.